Os06g0112300 Antibody

What is Os06g0112300 and what specific protein does this antibody detect?

Os06g0112300 is a gene locus in Oryza sativa Japonica Group that encodes a B3 domain-containing protein (UniProt: Q9LHY9). The antibody (CSB-PA885349XA01OFG) specifically recognizes this protein in research applications . Based on genomic data, this protein belongs to the B3 superfamily of plant-specific transcription factors characterized by their DNA-binding domain . The antibody targets epitopes unique to this protein, enabling detection in complex rice tissue samples for studying its expression patterns, localization, and molecular interactions.

How is Os06g0112300 classified within the B3 domain family of proteins?

Os06g0112300 encodes a B3 domain-containing protein that falls within the larger superfamily of plant-specific transcription factors. Based on sequence analysis, it appears to be related to other B3 domain proteins that function as transcription factors in regulatory networks controlling plant development and stress responses . The B3 domain superfamily in plants includes several subfamilies (ARF, RAV, LAV) that are differentiated by their domain architecture and function. Phylogenetic analysis comparing Os06g0112300 with other B3 domain proteins would be required to precisely determine its subfamily classification.

What are the predicted molecular characteristics of the Os06g0112300 protein?

The Os06g0112300 gene product contains the characteristic B3 DNA-binding domain, which is approximately 100-120 amino acids in length. Based on similar B3 domain proteins, the molecular weight of the full protein is likely between 30-70 kDa, though exact size should be confirmed experimentally via Western blotting. The protein likely functions as a transcription factor, binding to specific DNA sequences to regulate gene expression. Its expression profile in rice suggests potential roles in development, particularly in reproductive tissues or stress responses, as commonly observed with B3 domain proteins.

What is the recommended protocol for using Os06g0112300 antibody in Western blot analysis?

For optimal Western blotting with Os06g0112300 antibody, follow this protocol:

• Sample preparation:

  • Extract total protein from rice tissues using buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 1mM EDTA, and protease inhibitor cocktail

  • Quantify protein concentration using Bradford or BCA assay

  • Prepare samples in Laemmli buffer with DTT and heat at 95°C for 5 minutes

• Gel electrophoresis and transfer:

  • Load 20-50μg protein per lane on 10-12% SDS-PAGE gel

  • Run at 120V until adequate separation

  • Transfer to PVDF membrane (0.45μm) at 100V for 90 minutes in cold transfer buffer

• Immunoblotting:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with Os06g0112300 antibody (1:1000 dilution) overnight at 4°C

  • Wash 3×10 minutes with TBST

  • Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour

  • Wash 3×10 minutes with TBST

  • Develop using ECL substrate and image

Include positive control samples and verify protein loading with housekeeping protein detection (e.g., actin, tubulin).

How should chromatin immunoprecipitation (ChIP) be performed with Os06g0112300 antibody?

For ChIP experiments with Os06g0112300 antibody:

• Crosslinking and chromatin preparation:

  • Crosslink fresh rice tissue with 1% formaldehyde for 10 minutes under vacuum

  • Quench with 0.125M glycine for 5 minutes

  • Grind tissue in liquid nitrogen and extract nuclei in nuclei isolation buffer

  • Sonicate chromatin to generate 200-500bp fragments

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads for 1 hour at 4°C

  • Incubate pre-cleared chromatin with 3-5μg Os06g0112300 antibody overnight at 4°C

  • Add pre-washed protein A/G beads and incubate for 3 hours at 4°C

  • Wash beads sequentially with low salt, high salt, LiCl, and TE buffers

  • Elute DNA-protein complexes and reverse crosslinks at 65°C overnight

  • Treat with RNase A and Proteinase K

  • Purify DNA using phenol-chloroform extraction or column purification

• Analysis:

  • Perform qPCR with primers for potential target genes or sequence for genome-wide binding analysis

  • Include input control (non-immunoprecipitated chromatin) and IgG control

Since B3 domain proteins bind DNA in a sequence-specific manner, ChIP results can identify direct regulatory targets of Os06g0112300.

What considerations should be made when using Os06g0112300 antibody in immunohistochemistry?

For successful immunohistochemistry (IHC) with Os06g0112300 antibody:

• Tissue preparation:

  • Fix rice tissues in 4% paraformaldehyde for 12-24 hours

  • Dehydrate through ethanol series and embed in paraffin

  • Section at 5-8μm thickness

  • Deparaffinize and rehydrate sections

• Antigen retrieval and immunostaining:

  • Perform heat-induced epitope retrieval using citrate buffer (pH 6.0)

  • Block endogenous peroxidase activity with 3% H₂O₂

  • Block non-specific binding with 5% normal serum

  • Incubate with Os06g0112300 antibody (1:100-1:500) overnight at 4°C

  • Wash thoroughly with PBS

  • Apply appropriate secondary antibody and develop signal

  • Counterstain, dehydrate, and mount

• Critical optimization parameters:

  • Antibody dilution: Test multiple dilutions to determine optimal signal-to-noise ratio

  • Antigen retrieval method: Compare citrate buffer vs. EDTA buffer

  • Incubation time: Adjust based on tissue type and fixation duration

  • Controls: Include tissue known to not express Os06g0112300 and omit primary antibody as negative controls

Expected results include nuclear localization consistent with the protein's predicted function as a transcription factor.

How can researchers verify the specificity of Os06g0112300 antibody?

To comprehensively validate Os06g0112300 antibody specificity:

• Peptide competition assay:

  • Pre-incubate antibody with excess immunizing peptide (10× molar excess)

  • Perform Western blot with both peptide-blocked and unblocked antibody

  • Specific bands should be abolished or significantly reduced in peptide-blocked samples

• Genetic validation:

  • If available, use CRISPR/Cas9 knockout or RNAi knockdown rice lines

  • Compare antibody signal between wild-type and modified plants

  • Signal should be absent or significantly reduced in knockout/knockdown samples

• Recombinant protein validation:

  • Express tagged recombinant Os06g0112300 in E. coli or insect cells

  • Perform Western blot using both Os06g0112300 antibody and tag-specific antibody

  • Both antibodies should detect the same protein band

• Mass spectrometry validation:

  • Immunoprecipitate using Os06g0112300 antibody

  • Analyze precipitated proteins by mass spectrometry

  • Os06g0112300 peptides should be among the predominant identified proteins

Documenting these validation steps is essential for publication-quality research and ensures reliable interpretation of experimental results.

What strategies can address cross-reactivity with other B3 domain proteins?

B3 domain proteins share structural similarities that may lead to antibody cross-reactivity. To address this challenge:

• Computational analysis:

  • Perform sequence alignment of the antibody epitope region across rice B3 domain proteins

  • Identify proteins with high sequence similarity that may cross-react

  • Create a table of potential cross-reactive proteins based on epitope conservation

• Experimental verification:

  • Express multiple B3 domain family members as recombinant proteins

  • Test antibody reactivity against each protein via Western blot

  • Quantify relative signal intensity to create a specificity profile

• Biological validation:

  • Compare antibody signal with tissue-specific transcript levels of Os06g0112300

  • Discrepancies may indicate cross-reactivity with other proteins

  • Use RNA-seq data to identify tissues with differential expression of similar B3 domain proteins

• Technical solutions:

  • Pre-absorb antibody with recombinant proteins of closely related family members

  • Optimize blocking conditions and antibody concentration

  • Use monoclonal antibodies if available for higher specificity

Understanding the specificity profile allows appropriate experimental design and accurate data interpretation when studying Os06g0112300.

How can researchers investigate protein-protein interactions involving Os06g0112300?

To identify protein interaction partners of Os06g0112300:

• Co-immunoprecipitation (Co-IP):

  • Prepare native protein extracts from rice tissues

  • Immunoprecipitate with Os06g0112300 antibody

  • Analyze co-precipitated proteins by mass spectrometry or Western blot

  • Confirm interactions by reciprocal Co-IP with antibodies against identified partners

• Yeast two-hybrid screening:

  • Use Os06g0112300 as bait to screen rice cDNA library

  • Validate positive interactions by directed Y2H assays

  • Confirm in planta using techniques below

• Bimolecular fluorescence complementation (BiFC):

  • Create fusion constructs of Os06g0112300 and candidate interactors with split fluorescent protein fragments

  • Co-express in rice protoplasts or via Agrobacterium-mediated transformation

  • Visualize reconstituted fluorescence indicating protein interaction

  • Map interaction domains through truncation analysis

• Proximity-based labeling:

  • Generate fusion of Os06g0112300 with BioID or TurboID biotin ligase

  • Express in rice cells and provide biotin

  • Identify biotinylated proteins by streptavidin pulldown and mass spectrometry

These approaches can reveal Os06g0112300's role in transcriptional complexes and regulatory networks controlling rice development and stress responses.

How should researchers analyze the expression patterns of Os06g0112300 across different tissues and developmental stages?

To comprehensively characterize Os06g0112300 expression patterns:

• Systematic tissue sampling:

  • Collect diverse tissues: root, shoot, leaf (young/mature), inflorescence, developing seeds

  • Sample at defined developmental stages (seedling, vegetative, reproductive phases)

  • Consider diurnal time points to capture circadian regulation

• Quantitative analysis methods:

  • Western blot: Quantify band intensity normalized to loading controls

  • Immunohistochemistry: Perform digital image analysis of staining intensity

  • Complement protein data with qRT-PCR for transcript levels

  • Create expression heat maps across tissues and developmental stages

• Data visualization:

  • Generate tissue-specific expression profiles with statistical analysis

  • Create developmental timeline of expression changes

  • Compare protein levels with publicly available RNA-seq datasets

• Functional correlation:

  • Identify tissues/stages with peak expression

  • Correlate expression patterns with known developmental processes

  • Formulate hypotheses about biological functions based on spatiotemporal expression

This multi-method approach provides a comprehensive view of Os06g0112300 expression dynamics and informs functional studies.

What approaches can determine the DNA-binding specificity of Os06g0112300?

As a B3 domain-containing protein, Os06g0112300 likely binds specific DNA sequences. To characterize its binding preferences:

• ChIP-seq analysis:

  • Perform ChIP with Os06g0112300 antibody followed by next-generation sequencing

  • Identify genome-wide binding sites using peak-calling algorithms

  • Perform motif discovery to identify consensus binding sequences

  • Compare with known B3 domain binding motifs

• Protein-binding microarrays:

  • Express recombinant Os06g0112300 protein

  • Incubate with microarrays containing thousands of DNA sequence variants

  • Identify high-affinity binding sequences

  • Define position weight matrix of binding preferences

• EMSA (Electrophoretic Mobility Shift Assay):

  • Generate recombinant Os06g0112300 protein

  • Incubate with labeled DNA probes containing predicted binding sites

  • Assess binding through gel shift analysis

  • Confirm specificity through competition assays with unlabeled probes

• Integrative analysis:

  • Correlate binding sites with gene expression changes

  • Identify direct target genes regulated by Os06g0112300

  • Map binding sites relative to transcription start sites

  • Analyze chromatin features at binding locations

These approaches will reveal Os06g0112300's regulatory role in the rice genome and identify the biological processes it controls.

How can researchers investigate Os06g0112300's role in stress responses?

To characterize Os06g0112300's involvement in rice stress responses:

• Stress treatment experimental design:

  • Apply defined stress treatments: drought, salinity, temperature extremes, pathogen infection

  • Sample tissues at multiple time points (early, middle, late response)

  • Include recovery phase sampling

  • Maintain consistent controls and growth conditions

• Multi-level analysis:

  • Protein expression: Quantify changes in Os06g0112300 levels via Western blot

  • Subcellular localization: Track potential relocalization during stress via immunofluorescence

  • DNA binding: Perform ChIP-seq before and during stress to identify stress-specific targets

  • Post-translational modifications: Use phospho-specific antibodies or mass spectrometry to detect stress-induced modifications

• Functional validation:

  • Generate overexpression and knockdown/knockout rice lines

  • Compare stress tolerance phenotypes with wild-type plants

  • Measure physiological parameters (ROS levels, osmolyte content, photosynthetic efficiency)

  • Analyze expression of known stress-responsive genes

• Comparative studies:

  • Compare Os06g0112300 responses between stress-tolerant and susceptible rice varieties

  • Analyze evolutionary conservation across related cereals

  • Integrate findings with known stress response pathways

This systematic approach will determine whether Os06g0112300 is a promising candidate for improving stress tolerance in rice through breeding or biotechnological approaches.

What are potential solutions when Os06g0112300 antibody produces weak or no signal in Western blots?

When experiencing detection problems with Os06g0112300 antibody in Western blots:

• Sample preparation issues:

  • Ensure complete protein extraction with appropriate buffer composition

  • Verify protein integrity by Coomassie staining of duplicate gel

  • Consider adding additional protease inhibitors to prevent degradation

  • Test different tissue types where Os06g0112300 is likely more abundant

• Technical optimizations:

  • Increase antibody concentration (try 1:500 or 1:250 dilutions)

  • Extend primary antibody incubation (overnight at 4°C to 48 hours)

  • Use more sensitive detection systems (ECL Advance, fluorescent secondary antibodies)

  • Increase protein loading (50-100μg per lane)

  • Optimize transfer conditions (longer transfer time, lower methanol concentration)

• Epitope accessibility issues:

  • Try reducing agent concentration adjustment (standard vs. stronger DTT/BME)

  • Test different membrane types (PVDF vs. nitrocellulose)

  • Consider non-reducing conditions if epitope involves disulfide bonds

  • Adjust SDS concentration in sample buffer

• Antibody quality considerations:

  • Test new antibody lot

  • Store antibody according to manufacturer recommendations

  • Use positive control samples when available

Systematic troubleshooting through these parameters should identify the limiting factor and improve detection sensitivity.

How can researchers resolve non-specific background in immunohistochemistry with Os06g0112300 antibody?

To improve signal-to-noise ratio in immunohistochemistry:

• Blocking optimization:

  • Test different blocking agents (BSA, normal serum, commercial blockers)

  • Increase blocking time (2-3 hours or overnight)

  • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

  • Consider adding 0.1-0.3M glycine to reduce aldehyde-related background

• Antibody parameters:

  • Further dilute primary antibody (test 1:500, 1:1000, 1:2000)

  • Reduce incubation temperature (4°C instead of room temperature)

  • Extend wash steps (5-6 washes of 10 minutes each)

  • Pre-absorb antibody with acetone powder from rice tissue

• Tissue preparation considerations:

  • Optimize fixation time (over-fixation can increase background)

  • Test different antigen retrieval methods and durations

  • Quench endogenous peroxidase more thoroughly (extend H₂O₂ treatment)

  • Block endogenous biotin if using biotin-streptavidin detection

• Detection system adjustments:

  • Switch to polymer-based detection systems for lower background

  • Reduce substrate development time

  • Use fluorescent detection instead of chromogenic if appropriate

Careful optimization of these parameters should result in specific nuclear staining consistent with Os06g0112300's role as a transcription factor.

What control experiments are essential when publishing research using Os06g0112300 antibody?

For publication-quality research, include these critical controls:

• Antibody specificity controls:

  • Western blot showing single band at expected molecular weight

  • Peptide competition assay demonstrating signal abolishment

  • If available, samples from knockout/knockdown plants showing reduced signal

  • Pre-immune serum control (if using polyclonal antibody)

• Technical controls for immunohistochemistry:

  • No primary antibody control (secondary antibody only)

  • Isotype control (irrelevant primary antibody of same isotype)

  • Known positive and negative tissue controls

  • Serial dilution of primary antibody showing concentration-dependent signal

• Controls for ChIP experiments:

  • Input DNA (pre-immunoprecipitation chromatin)

  • IgG control immunoprecipitation

  • Positive control (primer for region likely to be bound)

  • Negative control (primer for region unlikely to be bound)

• Documentation requirements:

  • Complete antibody information (catalog number, lot, dilution)

  • Detailed methodological description enabling reproduction

  • Raw images of blots/IHC with molecular weight markers

  • Quantification of results with appropriate statistical analysis